Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial

Background: Although tyrosine kinase inhibitors (TKIs) are still recommended as the standard therapy in renal cell carcinoma (RCC), the high frequency of adverse events is a weakness of this therapy. Because royal jelly (RJ) possesses anti-inflammatory and antioxidant properties, we assessed its pro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicines (Basel)
Asıl Yazarlar: Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473390/
https://ncbi.nlm.nih.gov/pubmed/30577515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicines6010002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller